Form D · Other Technology
New View Surgical, Inc.
Andover, MA · CIK 0001721811
Offering snapshot reported Sep 30, 2022 · SEC filing
- Reported sold
- $7.02M Offering amount: $10M
- Investors reported
- 11 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Sep 15, 2022 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Sep 30, 2022 | Initial | $7,020,157 | No comparison | 11 | SEC filing |
| Sep 16, 2021 | Initial | $5,639,874 | No comparison | Not reported | SEC filing |
| Apr 6, 2021 | Initial | $2,067,803 | No comparison | 52 | SEC filing |
| Nov 6, 2017 | Initial | $1,088,438 | No comparison | 39 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-460373
Source: Form D, filed Sep 30, 2022. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Nancy Briefs | Director |
| Scott Flora | Director |
| Bryce Klontz | Director, Executive |
| Arthur C. Mc Kinley | Director, Executive |
| Melvin B. Prenovitz | Director, Executive |
| Mark H. Schneider | Director |
| Thomas Testa | Director |
| John Younger | Director |
Issuer details
Industry: Other Technology (See others in industry)
Address:
300 Brickstone Square Suite 201
Andover, MA, 01810
Andover, MA, 01810